Regence BCBS Medical Policy Updates – July 2022

Click here to view the Regence BCBS Blue Cross Blue Shield Medical Policy Updates »

July 2022 Regence BCBS Medical Policy Updates:

• Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder
• Applied Behavior Analysis Initial Assessment for the Treatment of Autism Spectrum Disorder
• Artificial Intervertebral Disc
• Artificial Pancreas Device System (APDS)
• Bioengineered Skin and Soft Tissue Substitutes and Amniotic Products
• Bioimpedance Devices for Detection and Management of Lymphedema
• Blepharoplasty and Brow Ptosis Repair
• Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
• Cholesterol Management in Adults
• Chromosomal Microarray (CMA) Testing for the Evaluation of Products of Conception and Pregnancy Loss
• Chromosomal Microarray Analysis (CMA) for the Genetic Evaluation of Patients with Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies
• Cooling Devices Used in the Home Setting
• Cosmetic and Reconstructive Surgery
• COVID-19 Testing
• Cranial Electrostimulation Therapy (CES)
• Cytochrome p450 Genotyping
• Deep Brain Stimulation
• Detection of Circulating Tumor Cells in the Management of Patients with Cancer
• Dynamic Stabilization of the Spine
• Eating Disorder Inpatient Treatment
• Eating Disorder Intensive Outpatient
• Eating Disorder Partial Hospitalization
• Eating Disorder Residential Treatment
• Expanded Molecular Testing of Cancers to Select Targeted Therapies
• Gastric Electrical Stimulation
• Gene Expression Profiling for Melanoma
• Gene-Based Tests for Screening, Detection, and/or Management of Prostate Cancer
• Genetic Testing for CADASIL Syndrome
• Guidelines for the Diagnosis and Treatment of Asthma in Children, Adolescents, and Adults
• Hematopoietic Cell Transplantation for Autoimmune Diseases
• Hematopoietic Cell Transplantation for Light-Chain (AL) Amyloidosis or Waldenström Macroglobulinemia
• Hyperoxemic Reperfusion Therapy
• Hypoglossal Nerve Stimulation
• Hypoglossal Nerve Stimulation
• Identification of Microorganisms Using Nucleic Acid Probes
• Implantable Cardioverter Defibrillator
• Implantable Peripheral Nerve Stimulation for Chronic Pain of Peripheral Nerve Origin
• In Vitro Chemoresistance and Chemosensitivity Assays
• Invasive Prenatal Fetal Diagnostic Testing Using Chromosomal Microarray Analysis (CMA)
• Investigational Gene Expression and Multianalyte Testing
• Islet Transplantation
• Laser Treatment for Port Wine Stains
• Leadless Cardiac Pacemakers
• Liver Transplant
• Mastectomy as a Treatment of Gynecomastia
• Measurement of Lipoprotein-Associated Phospholipase A2 (Lp- PLA2) in the Assessment of Cardiovascular Risk
• New and Emerging Medical Technologies and Technologies
• Noninvasive Prenatal Testing to Determine Fetal Aneuploidies, Microdeletions, and Twin Zygosity using Cell-Free DNA
• Orthopedic Applications of Stem Cell Therapy
• Ovarian, Internal Iliac, and Gonadal Vein Embolization, Ablation, and Sclerotherap
• Panniculectomy
• PathFinderTG® Molecular Testing
• Percutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty
• Prefabricated Oral Appliances for Obstructive Sleep Apnea
• Psychiatric Inpatient Hospitalization
• Psychiatric Intensive Outpatient
• Psychiatric Partial Hospitalization
• Psychiatric Residential Treatment
• Quantitative Sensory Testing
• Retinal Prosthesis
• Rhinoplasty
• Sacroiliac Joint Fusion
• Sequencing-based Tests to Determine Fetal Aneuploidies and  Microdeletions from Maternal Plasma DNA
• Sphenopalatine Ganglion Block for Headache and Pain
• Spinal Cord Stimulation
• Stereotactic Radiosurgery and Stereotactic Body Radiation  Therapy of Intracranial, Skull Base, and Orbital Sites
• Subacromial Balloon Placement
• Surgical Treatments for Hyperhidrosis
• Treatment for Diabetes in Adults
• Urine Drug Testing for Substance Abuse and Chronic Pain
• Vagus Nerve Stimulation
• Varicose Vein Treatment
• Ventral Hernia Repair
• Whole Exome and Whole Genome Sequencing

Click here to view the Regence BCBS Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.